![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- American College of Obstetrician and Gynecologists. Response to Searle's drug warning on misoprostol. ACOG committee opinion no. 248. American College of Obstetrician and Gynecologists, Washington, DC 2000
- Chapman S J, Crispens M, Owen J. Complications of midtrimester pregnancy termination: The effect of prior caesarean delivery. American Journal of Obstetrics and Gynecology 1996; 175: 889–892
- Daskalakis A J, Mesogitis S A, Papantoniou N E, et al. Misoprostol for second trimester termination in women with prior caesarean section. British Journal of Obstetrics and Gynaecology 2005; 112: 97–99
- Dickinson J E. Misoprostol for second trimester pregnancy termination in women with a prior caesarean section. Obstetrics and Gynecology 2005; 105: 352–356
- Gemzell-Danielsson K, Ostlund E. Termination of second trimester pregnancy with mifepristone and gemeprost: The clinical experience of 197 consecutive cases. Acta Obstetricia et Gynecologica Scandinavica 2000; 79: 702–706
- Goldberg A B, Greenberg M B, Darney P D. Misoprostol and pregnancy. New England Journal of Medicine 2001; 344: 38
- Jwarah E, Greenhalf J O. Rupture of the uterus after 800 μg misoprostol given vaginally for termination of pregnancy. British Journal of Obstetrics and Gynaecology 2000; 107: 807
- Lydon-Rochelle M, Holt V L, Easterling T R, et al. Risk of uterine rupture during labour among women with a prior caesarean delivery. New England Journal of Medicine 2001; 345: 3–8
- Xu J, Chen H, Ma T, et al. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol. International Journal of Gynaecology and Obstetrics 2001; 72: 245–251